Patenting Bioresearch And Drug Development In the Wake of The U.S. Supreme Court The U.S. Supreme Court recently issued a landmark patent decision giving drug companies more leeway to develop new medicines, ruling that compounds patented by rivals do not bar them from starting research on new competing medications. The unanimous ruling in Merck KGaA v. Integra ...
[Added: 25 Aug 2005 Hits: 248 Words: 617]